Requirement of the Akt/β-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of Slug

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2107-2115

  Saegusa, Makoto ^a   Hashimura, Miki ^a   Kuwata, Takeshi ^b   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SLUG; UVOMORULIN;

ARTICLE; CARCINOGENESIS; CARCINOSARCOMA; CLINICAL ARTICLE; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MESENCHYME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; UTERUS CARCINOMA; UTERUS CARCINOSARCOMA;

EID: 67049164999     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081018     Document Type: Article

References (44)

1. McCluggage WG: Malignant biphasic uterine tumors: carcinosarcomas or metaplastic carcinomas? J Clin Pathol 2002, 55:321-325
2. Fujii H, Yoshida M, Gong ZX, Matsumoto T, Hamano Y, Fukunaga M, Hruban RH, Gabrielson E, Shirai T: Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000, 60:114-120 (Pubitemid 30058740)
3. Matsumoto T, Fujii H, Arakawa A, Yamasaki S, Sonoue H, Hattori K, Kajiyama Y, Hirose S, Tsurumaru M: Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma. Hum Pathol 2004, 35:322-327 (Pubitemid 38339606)
4. Gupta GP, Massague J: Cancer metastasis: building a framework. Cell 2006, 127:679-695 (Pubitemid 44781029)
5. Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23:912-923 (Pubitemid 32972691)
6. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454
7. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142 (Pubitemid 43278296)
8. Christiansen JJ, Rajasekara AK: Reassessing epithelia to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006, 66:8319-8326
9. Tarin D: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000
10. Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2006, 68:989-997
11. Larue L, Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 2005, 24:7443-7454 (Pubitemid 41637984)
12. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83 (Pubitemid 30785917)
13. Hajra KM, Chen DY, Fearon ER: The Slug zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62:1613-1618 (Pubitemid 34408479)
14. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7:1267-1278 (Pubitemid 32607360)
15. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939 (Pubitemid 38798858)
16. Fukumoto S, Hsieh C-M, Maemura K, Layne MD, Yet S-F, Lee K-H, Matsui T, Rosenzweig A, Taylor WG, Rubin JS, Perrella MA, Lee M-E: Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem 2001, 276:17479-17483 (Pubitemid 37411564)
17. Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C, Paramio JM: Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 2005, 65:9678-9686 (Pubitemid 41541443)
18. Menges CW, Baglia LA, Lapoint R, McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 2006, 66:5555-5559 (Pubitemid 43927104)
19. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, Garcia de Herreros A, Bellacosa A, Larue L: Activation of NF-κB by Akt upregulates Snail expression and induces epithelial mesenchyme transition. Oncogene 2007, 26:7445-7456 (Pubitemid 350158710)
20. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I: β-Catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 2004, 164:1739-1749 (Pubitemid 38529776)
21. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I: Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells. Lab Invest 2005, 85:768-779 (Pubitemid 40799706)
22. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I: Crosstalk between NF-κB/p65 and β-catenin/TCF4/p300 signaling pathway through alterations in GSK-3β expression during trans-differentiation of endometrial carcinoma cells. J Pathol 2007, 213:35-45 (Pubitemid 47354564)
23. Nishida M: Ishikawa cells: opening of in vitro hormone research on endometrial carcinoma. Cell and Molecular Biology of Endometrial Carcinoma. Edited by Kuramoto H, Nishida M. Tokyo, Springer-Verlag, 2003, pp 35-60
24. Kuramoto H, Hamano M, Imai M, Fujisawa T, Kamata Y, Arai T, Kawaguchi M: Hec-1 cells: establishment of an in vitro experimental system in endometrial carcinoma. Cell and Molecular Biology of Endometrial Carcinoma. Edited by Kuramoto H, Nishida M. Springer-Verlag, 2003, pp 3-34
25. Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y: Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-mesenchymal transition. Cancer Res 2008, 68:5104-5112
26. INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells. Int J Cancer 2006, 119:2294-2303
27. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee- Kwon W, Donowitz M, Tsichlis PN, Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003, 63:2172-2178 (Pubitemid 36538623)
28. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS: Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005, 171:1023-1034 (Pubitemid 41815834)
29. Bellacosa A, Testa JR, Moore R, Larue L: A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol Ther 2004, 3:268-275 (Pubitemid 41350878)
30. Weston CR, Davis RJ: Signal transduction: signaling specificity - a complex affair. Science 2001, 292:2439-2440
31. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789 (Pubitemid 26004411)
32. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z: Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity. J Biol Chem 2007, 282:11221-11229 (Pubitemid 47100795)
33. Viatour P, Merville MP, Bours V, Chariot A: Phosphorylation of NFkappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52 (Pubitemid 40093740)
34. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82-85 (Pubitemid 29418447)
35. Criswell TL, Arteaga CL: Modulation of NF-κB activity and E-cadherin by the type III transforming growth factor B receptor regulates cell growth and motility. J Biol Chem 2007, 282:32491-32500 (Pubitemid 350106480)
36. Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafe M: The basal-like breast carcinoma phenotype is regulated by Slug gene expression. J Pathol 2007, 214:25-37
37. Roose J, Clevers H: TCF transcription factors: molecular switches in carcinogenesis. Biochem Biophys Acta 1999, 1424:M23-M37 (Pubitemid 29488713)
38. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426 (Pubitemid 29180374)
39. Damals A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M: Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J 2001, 20:4912-4922
40. Vallin J, Thuret R, Giacomello E, Faraldo MM, Thiery JP, Broders F: Cloning and characterization of three Xenopus Slug promoters reveal direct regulation by Lef/β-catenin signaling. J Biol Chem 2001, 276:30350-30358 (Pubitemid 37385119)
41. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A: Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK. J Cell Biol 2003, 163:847-857 (Pubitemid 37517891)
42. -/- colon carcinoma. Science 1997, 275:1784-1787
43. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutation in β-catenin or APC. Science 1997, 275:1787-1790 (Pubitemid 27136715)
44. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792 (Pubitemid 27136716)